iX Biopharma Ltd.'s total assets for Q4 2021 were $18.86M, a decrease of -19.46% from the previous quarter. SG:42C total liabilities were $7.15M for the fiscal quarter, a 2.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.